Chemed Price to Book Ratio 2012-2026 | CHE
Historical price to book ratio values for Chemed (CHE) over the last 10 years. The current price to book ratio for Chemed as of May 13, 2026 is 5.58.
| Chemed Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-05-13 | 424.04 | 5.56 | |
| 2025-09-30 | 446.56 | $76.31 | 5.85 |
| 2025-06-30 | 484.98 | $82.56 | 5.87 |
| 2025-03-31 | 612.32 | $81.09 | 7.55 |
| 2024-12-31 | 526.73 | $76.87 | 6.85 |
| 2024-09-30 | 596.95 | $82.78 | 7.21 |
| 2024-06-30 | 538.49 | $80.51 | 6.69 |
| 2024-03-31 | 636.62 | $78.46 | 8.11 |
| 2023-12-31 | 579.52 | $73.69 | 7.86 |
| 2023-09-30 | 514.70 | $67.91 | 7.58 |
| 2023-06-30 | 536.04 | $63.42 | 8.45 |
| 2023-03-31 | 531.78 | $58.84 | 9.04 |
| 2022-12-31 | 504.39 | $53.70 | 9.39 |
| 2022-09-30 | 431.06 | $48.73 | 8.85 |
| 2022-06-30 | 463.11 | $46.16 | 10.03 |
| 2022-03-31 | 499.41 | $44.74 | 11.16 |
| 2021-12-31 | 521.18 | $41.79 | 12.47 |
| 2021-09-30 | 457.88 | $50.87 | 9.00 |
| 2021-06-30 | 466.74 | $55.59 | 8.40 |
| 2021-03-31 | 451.99 | $58.51 | 7.73 |
| 2020-12-31 | 523.14 | $56.65 | 9.23 |
| 2020-09-30 | 471.48 | $50.48 | 9.34 |
| 2020-06-30 | 442.44 | $47.39 | 9.34 |
| 2020-03-31 | 424.63 | $43.28 | 9.81 |
| 2019-12-31 | 430.26 | $45.58 | 9.44 |
| 2019-09-30 | 408.70 | $42.21 | 9.68 |
| 2019-06-30 | 352.91 | $39.05 | 9.04 |
| 2019-03-31 | 312.75 | $37.08 | 8.44 |
| 2018-12-31 | 276.55 | $37.25 | 7.42 |
| 2018-09-30 | 311.70 | $35.67 | 8.74 |
| 2018-06-30 | 313.57 | $34.76 | 9.02 |
| 2018-03-31 | 265.65 | $31.98 | 8.31 |
| 2017-12-31 | 236.34 | $33.69 | 7.01 |
| 2017-09-30 | 196.26 | $30.08 | 6.52 |
| 2017-06-30 | 198.38 | $28.48 | 6.96 |
| 2017-03-31 | 176.97 | $31.30 | 5.65 |
| 2016-12-31 | 155.16 | $32.38 | 4.79 |
| 2016-09-30 | 136.19 | $30.22 | 4.51 |
| 2016-06-30 | 131.36 | $28.69 | 4.58 |
| 2016-03-31 | 130.28 | $29.46 | 4.42 |
| 2015-12-31 | 143.82 | $30.55 | 4.71 |
| 2015-09-30 | 127.94 | $29.12 | 4.39 |
| 2015-06-30 | 125.46 | $28.41 | 4.42 |
| 2015-03-31 | 114.06 | $28.07 | 4.06 |
| 2014-12-31 | 100.75 | $26.72 | 3.77 |
| 2014-09-30 | 97.91 | $25.57 | 3.83 |
| 2014-06-30 | 88.99 | $25.86 | 3.44 |
| 2014-03-31 | 84.74 | $25.57 | 3.31 |
| 2013-12-31 | 72.42 | $25.53 | 2.84 |
| 2013-09-30 | 67.40 | $24.34 | 2.77 |
| 2013-06-30 | 68.08 | $25.93 | 2.63 |
| 2013-03-31 | 74.98 | $25.73 | 2.91 |
| 2012-12-31 | 64.16 | $24.46 | 2.62 |
| 2012-09-30 | 64.62 | $24.73 | 2.61 |
| 2012-06-30 | 56.21 | $23.55 | 2.39 |
| 2012-03-31 | 58.13 | $22.71 | 2.56 |
| 2011-12-31 | 47.37 | $21.71 | 2.18 |
| 2011-09-30 | 50.69 | $21.55 | 2.35 |
| 2011-06-30 | 60.26 | $22.97 | 2.62 |
| 2011-03-31 | 61.14 | $21.91 | 2.79 |
| 2010-12-31 | 58.17 | $21.71 | 2.68 |
| 2010-09-30 | 52.05 | $23.51 | 2.21 |
| 2010-06-30 | 49.79 | $22.61 | 2.20 |
| 2010-03-31 | 49.45 | $21.91 | 2.26 |
| 2009-12-31 | 43.52 | $21.10 | 2.06 |
| 2009-09-30 | 39.72 | $20.26 | 1.96 |
| 2009-06-30 | 35.63 | $19.42 | 1.83 |
| 2009-03-31 | 35.06 | $18.56 | 1.89 |
| 2008-12-31 | 35.79 | $17.70 | 2.02 |
| 2008-09-30 | 36.89 | $15.69 | 2.35 |
| 2008-06-30 | 32.85 | $15.50 | 2.12 |
| 2008-03-31 | 37.81 | $15.43 | 2.45 |
| 2007-12-31 | 50.00 | $15.21 | 3.29 |
| 2007-09-30 | 55.56 | $14.36 | 3.87 |
| 2007-06-30 | 59.19 | $13.58 | 4.36 |
| 2007-03-31 | 43.67 | $16.43 | 2.66 |
| 2006-12-31 | 32.95 | $16.32 | 2.02 |
| 2006-09-30 | 28.69 | $15.89 | 1.81 |
| 2006-06-30 | 48.43 | $15.71 | 3.08 |
| 2006-03-31 | 52.64 | $15.23 | 3.46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |